Getting started with the 340b program If your hospital isn’t already 340B registered and eligible, you might want to refer to our previous blog post, Are you ready to enroll in the 340B program? What is a Specialty Pharmacy? The National Association of Specialty Pharmacy defines a specialty pharmacy as a state-licensed pharmacy that solely … Read More
Specialty Pharmacy
Understanding The 340B Program Requirements
POST OUTLINE 1) What Is The 340B Drug Pricing Program? How does the 340B program work? How much revenue can my hospital generate from the 340B program? 2) Who qualifies for the 340B program? What is a 340B Covered Entity? Facilities included in the 340B program 3) Understanding the 340B program requirements for eligibility Government-owned … Read More
Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals.
As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. From a financial perspective, the number one reason a 340B hospital should consider an onsite specialty pharmacy is the significantly increased potential for generating 340B savings — and for passing-along those savings to patients … Read More
Starting A 340B Specialty Pharmacy: What Does The Process Look Like?
Opening an onsite specialty pharmacy is extremely challenging — particularly given the effort required just to get access to purchase specialty meds, and then to get “In Network” with PBMs. That said, ProxsysRx has developed a proven process for meeting those challenges. Owning a successful specialty pharmacy starts with optimizing your 340B program (For an … Read More
How Can Your 340B Hospital Pay For Its Own Specialty Pharmacy?
Since 2019, ProxsysRx has generated more than $500 million in 340B savings and revenue for the health systems we serve — and yes, we’ve learned to overcome many of even the toughest manufacturers restrictions. We work with hospitals to unlock pharmacy’s potential throughout the continuum of care. We optimize revenues from their 340B programs and … Read More
340B Outlook For 2024: Change. Change. And More Change.
What we’ve learned. What it means for your 340B program. Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. In spite of drug manufacturer restrictions, every one of the 13 health systems we … Read More